Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/42869
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorRada Bravo, Ana Mercedes-
dc.contributor.authorCorrea, Adriana-
dc.contributor.authorRestrepo Pineda, Eliana-
dc.contributor.authorCapataz Tafur, Cesar Antonio-
dc.date.accessioned2024-10-25T16:22:14Z-
dc.date.available2024-10-25T16:22:14Z-
dc.date.issued2022-
dc.identifier.citationRada AM, Correa A, Restrepo E, Capataz C. Escherichia coli ST471 Producing VIM-4 Metallo-β-Lactamase in Colombia. Microb Drug Resist. 2022 Mar;28(3):288-292. doi: 10.1089/mdr.2021.0031.spa
dc.identifier.issn1076-6294-
dc.identifier.urihttps://hdl.handle.net/10495/42869-
dc.description.abstractABSTRACT: An Escherichia coli isolate sequence-type 471 (ST471) producing Verona integron-encoded metallo-blactamases (VIM)-4 was recovered from a rectal swab in a patient without travel records with osteomyelitis in Colombia. The isolate carried a class 1 integron-borne blaVIM-4 gene with a 170-bp duplication in the 3' end of the gene, preceded by an aac(6¢)-Ib gene. The genetic environment of blaVIM-4, blaCMY-2, and sul2 genes showed similarities to the backbone of pKKp4, an IncA/C-type plasmid from a Klebsiella neumoniae strain carrying blaVIM-4 recovered in Kuwait. This is the first report of blaVIM-4 in Enterobacterales in South America. Our results suggest that blaVIM-4 gene was found on an IncA/C-type plasmid that could play a role in the spread of VIM-4 carbapenemase in Colombia.spa
dc.format.extent5 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherMary Ann Liebertspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleEscherichia coli ST471 Producing VIM-4 Metallo-β-Lactamase in Colombiaspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupBacterias y Cáncerspa
dc.identifier.doi10.1089/mdr.2021.0031-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1931-8448-
oaire.citationtitleMicrobial Drug Resistancespa
oaire.citationstartpage288spa
oaire.citationendpage292spa
oaire.citationvolume28spa
oaire.citationissue3spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
dc.publisher.placeLarchmont, Estados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAntibacterianos-
dc.subject.decsAnti-Bacterial Agents-
dc.subject.decsFarmacorresistencia Bacteriana Múltiple-
dc.subject.decsDrug Resistance, Multiple, Bacterial-
dc.subject.decsGenes Bacterianos-
dc.subject.decsGenes, Bacterial-
dc.subject.decsPruebas de Sensibilidad Microbiana-
dc.subject.decsMicrobial Sensitivity Tests-
dc.subject.decsbeta-Lactamasas-
dc.subject.decsbeta-Lactamases-
dc.subject.decsEscherichia coli-
dc.description.researchgroupidCOL0070457spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000900-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D024901-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D005798-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D008826-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D001618-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004926-
dc.relation.ispartofjournalabbrevMicrob. Drug. Resist.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
RadaAna_2022_Escherichia_coli_ST471.pdfArtículo de investigación3.53 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons